2Esien SA, Miller DK,Woodward RS,et. al. The effect of prescribed daily dose frequency on patient medication compliance [ J ]. Arch Intern Med, 1990, 150(9) :1881 - 1884.
3Courts JAP, Gibson NA, Paton JY. Measuring compliance with inhaled medication in asthma[J]. Arch Dis Child, 1992, 67(3):332 - 333.
4Bateman ED, Britton M, Carrillo J, et al. Salmeterol/fluticasone (50/100 μ.g) combination inhaler a new, effective and well tolerated treatment for asthma[J]. Clin Drug Invest, 1998, 16(3):193 -201.
6Pauwels RA, Buist AS, Calverley PM, et al. On behalf of the GOLD Scientific Committee. Global strategy for the diagnosis, management,and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary [Z] .AmJ Respir Crit Care Med.2001 Apr; 163 (5):1256 - 1276.
7Jarvis B, Markham A.Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease [J] .Drugs Aging.2001; 18(6): 441 - 72.
8Howarth PH, Beckett P, Dahl R.The effect of long acting beta2 - agonists on airway inflammation in asthmatic patients [ J ] .Respir Med.2000; 94 Supp1 F: S22 - 27.
9Van den Berg NJ.Salmeterol/fluticasone propionate (50/100μg) in combination in a Diskus inhaler (Seretide) is effective and sale in children with asthma [J] .Paediatric Pulmonology.2000, 10 (1): 200.
10Pelaia G, Vatrella A, Cuda G, et al. Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases [ J ] .Life Sci.200321; 72 (14): 1549-61.
4Global Initiative for Asthma(GINA). The Global Strategy for Asthma management and Prevention[M]. Global Initiative for Asthma(GINA), updated 2009. Availahle online at www. gi nasthma, org:last accessed April 2010.
5Bergmann KC, Lindemann L, Braun R, et al. Salmeterol/fluti- casone propionate (50/250μg) combination is superior to doub- le dose fluticasone(500μg) for the treatment of symptomatic moderate asthma[J]. Swiss Med Wkly,2004,134: 50-58.
6Busse W,Koenig SM, Oppenheimer J, et al. Steroid-sparing ef- fets of fluticasone propionate 100t,g and salmeterol 50 μg ad- ministered twice daily in a single product in patients previously controlled with Fluticasone propionate 250t, g administered twice daily[J]. J Allergy Clin Irnmunol, 2003,111 (1) : 57-65.
7Kline GS. A phase IV, multi-centre, double-blind, parallel group,randomised study comparing seretide (50/100 mg bid) via the evohaler (MDI-HFA) with flixotide (250 mg bid) via the evohaler (MDI-HFA) in asthmatics with significant smok- ing history. GSK Study ID: SAM40120,2005.
8Kline GS. A twelve-week multi-centre, randomised, double- blind, parallel group, comparative trial of advair 50/100 mg dis- kus inhalation device bid versus flovent 250 mg diskus inhala tion device bid in adolescents and adults with persistent asthma (program of advair control and ffectiveness-Advair low dose [PACE ALDI). GSK Study ID: SAM40090,2005.
9Kotaniemi J, Tilling B, Oien T, et al. A double blind, random- ised, parallel group study over 12 weeks comparing SeretideTM (50/100 μg bid Diskus^TM) versus FlixotideTV(250 μg bid Dis- kusTM) as first line regular asthma treatment for steroid-native adult patients[J]. Am J Respir Crit Care Med,2003,167(7): A893.
10Murray CS, Custovic A, Lowe LA,et al. Effect of addition of Salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma[J]. Aller- gy and Asthma Proceedings,2010,31:415-421.
4H Ross Anderson,Jon G Ayres,Patricia M Sturdy,J Martin Bland,Barbara K Butland,Clare Peckitt,Jennifer C Taylor,Christina R Victor,王同德（译）,代华平（校）.支气管扩张剂治疗与哮喘死亡:病例对照研究[J].英国医学杂志中文版,2005,8(4):220-222.
